My Companies
Notification
Account
Log Out
Login
Aurobindo Pharma's subsidiary, Aurobindo Pharma USA Inc., received US FTC approval to acquire 100% of Lannett Company LLC. The company anticipates the transaction will close before the end of June 2026.
Aurobindo Pharma Unit I Receives US FDA Warning Letter
Aurobindo Pharma's Unit-III Gets FDA OAI After 11 Inspection Observations